These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 3079355)

  • 1. [Immunologic deficit in Hodgkin's disease. Clinical reflections and pathogenetic implications].
    Maggi E; Romagnani S; Ricci M
    Ann Ital Med Int; 1986 Mar; 1(1):54-65. PubMed ID: 3079355
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunodeficiencies in Hodgkin's Disease. Part II: B cell immunity, complement systems and phagocytic cell systems.
    Gupta S
    Clin Bull; 1981; 11(3):110-9. PubMed ID: 7039866
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunodeficiencies in Hodgkin's disease. Part I: T cell-mediated immunity.
    Gupta S
    Clin Bull; 1981; 11(2):58-65. PubMed ID: 6459892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Splenectomy in lymphogranulomatosis].
    Simbirtseva LP
    Vopr Onkol; 1980; 26(3):97-102. PubMed ID: 6966108
    [No Abstract]   [Full Text] [Related]  

  • 5. Invited discussion: kinetic approach to the study of cell-mediated immunity in Hodgkin's disease.
    Hersh EM
    Natl Cancer Inst Monogr; 1973 May; 36():123-4. PubMed ID: 4744573
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunology in Hodgkin's disease.
    Gollerkeri MP
    Indian J Cancer; 1972 Dec; 9(4):312-5. PubMed ID: 4144182
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunological aspects of lymphogranulomatosis].
    Blokhina NG; Agafonov VA; Bykovskaia SN; Naumova ER; Raushenbakh MO
    Ter Arkh; 1984; 56(10):125-30. PubMed ID: 6098042
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunity and hypersensitivity in Hodgkin's lymphoma].
    Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
    Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunology of Hodgkin's disease].
    Hoerni B; Chauvergne J; Hoerni-Simon G
    Bord Med; 1972 Jun; 5(11):1299-302. PubMed ID: 5054781
    [No Abstract]   [Full Text] [Related]  

  • 10. International symposium on Hodgkin's disease. Session 2. Histopathology and experimental cytology. Invited discussion: Synthesis and implications for the etiology, pathogenesis and spread of Hodgkin's disease.
    Berard CW
    Natl Cancer Inst Monogr; 1973 May; 36():261-3. PubMed ID: 4355349
    [No Abstract]   [Full Text] [Related]  

  • 11. [Impaired immunologic reactivity as pacemaker for lymphoma development (author's transl)].
    Krüger G
    Verh Dtsch Ges Pathol; 1971; 55():200-4. PubMed ID: 4130717
    [No Abstract]   [Full Text] [Related]  

  • 12. International Symposium on Hodgkin's disease. Session 1. Epidemiology and etiology. Part 4. Synthesis and epidemiological implications. Invited discussion: Synthesis and epidemiologic implications.
    Miller RW
    Natl Cancer Inst Monogr; 1973 May; 36():171-2. PubMed ID: 4270377
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunity in Hodgkin's lymphoma].
    Danieli G; Montroni M; Leoni P; Magelli L; Totti S
    G Clin Med; 1975; 56(1):39-56. PubMed ID: 770222
    [No Abstract]   [Full Text] [Related]  

  • 14. The immunohistology of Hodgkin's disease--Reed-Sternberg cells and their variants.
    Angel CA; Warford A; Campbell AC; Pringle JH; Lauder I
    J Pathol; 1987 Sep; 153(1):21-30. PubMed ID: 3499498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses to tests of cell mediated immunity before, during and after BCG administration in Hodgkin's disease.
    Lenzini L; Bracci R; Rottoli P; Rottoli L
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:300. PubMed ID: 4546904
    [No Abstract]   [Full Text] [Related]  

  • 16. [Subpopulations of immunocompetent cells in patients with liver cirrhosis studied using monoclonal antibodies].
    Podymova SD; Rachvelishvili NB; Tabagari DZ
    Ter Arkh; 1988; 60(11):49-53. PubMed ID: 3266373
    [No Abstract]   [Full Text] [Related]  

  • 17. Implications of persistent T cell abnormalities for the etiology of Hodgkin's disease.
    Fisher RI
    Cancer Treat Rep; 1982 Apr; 66(4):681-7. PubMed ID: 6210434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The target cell for antilymphocyte antibodies in Hodgkin's disease].
    Del Giacco GS; Manconi PE; Tognella S; Mantovani G; Turno R; Grifoni V
    Boll Ist Sieroter Milan; 1974; 53(4):562-4. PubMed ID: 4615725
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hodgkin's disease. Histology--immunohistology--immunology].
    Möller P
    Norm Pathol Anat (Stuttg); 1986; 51():1-77. PubMed ID: 3495783
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hodgkin's disease--an atypical immune reaction].
    Trepel F; Schick P
    Med Klin; 1977 Jun; 72(23):1003-18. PubMed ID: 327241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.